Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

The preclinical data presented at ACR Convergence underscore the exceptional potential of our targeted protein degradation strategy compared to kinase inhibition for both BTK and IRAK4, which are ...

While many people living with chronic pain require medication, there is growing interest in non-pharmacological approaches ...